BridgeBio Pharma BBIO Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's inventories?
- BridgeBio Pharma (BBIO) reported inventories of $32.98M in Q1 2026.
- How has BridgeBio Pharma's inventories changed year-over-year?
- BridgeBio Pharma's inventories increased by 734.1% year-over-year, from $3.95M to $32.98M.
- What does inventories mean?
- The total value of all goods and materials the company currently has in stock.
- How do you interpret inventories?
- Rising inventory levels may signal anticipated sales growth or potential overstocking, while declining levels could indicate supply chain constraints.
- How does inventories compare across companies?
- Higher for commercial-stage pharmaceutical companies compared to early-stage research-focused entities.